Trianni's Incubator/Accelerator Round

Trianni raised a round of funding on February 01, 2017. Investors include JLabs.

Trianni's lead technology, The Trianni Mouse, offers scientists easy-to-apply monoclonal antibody discovery optimized for the isolation of humanized therapeutic candidates.…

Articles about Trianni's Incubator/Accelerator Round: